Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 1ClinicalTrials.gov

Phase 1 Study to Evaluate Safety, Tolerability and Immunogenicity of a New Recombinant Protein-based Vaccine (ARVAC CG) Against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), in a Population of Healthy Adult Volunteers Previously Vaccinated Against SARS-CoV-2 Virus.

INTERVENTIONALInicio: 20 de abr de 2022ID: NCT05656508

CompletadoClinicalTrials.gov

REAL-WORLD OBSERVATIONAL STUDY OF ZAVICEFTA (REGISTERED) (CEFTAZIDIME-AVIBACTAM) TO CHARACTERIZE USE PATTERNS, EFFECTIVENESS AND SAFETY - EZTEAM STUDY

OBSERVATIONALInicio: 27 de nov de 2018ID: NCT03923426

DesconocidoClinicalTrials.gov

Incidence and Risk Factors for Developing Infections in Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae

OBSERVATIONALInicio: 1 de jul de 2022ID: NCT05492539

Aún no reclutaClinicalTrials.gov

Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age Using Propensity Score Matching in Pediatric Inpatient Units"

OBSERVATIONALInicio: 1 de oct de 2025ID: NCT07202585

CompletadoClinicalTrials.gov

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)

OBSERVATIONALInicio: 21 de feb de 2013ID: NCT01729455

CompletadoFase 4ClinicalTrials.gov

A Descriptive, Phase IV, Open-label, Single-arm Multi-center Study to Assess the Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Healthy Toddlers 12 to 23 Months of Age Who Had Been Primed With at Least 1 Dose of Another Quadrivalent Meningococcal Conjugate Vaccine, ie, Nimenrix® (MCV4-TT) or Menveo® (MCV4-CRM), in Infancy.

INTERVENTIONALInicio: 7 de sept de 2023ID: NCT05929651

CompletadoFase 4ClinicalTrials.gov

Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well-Controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of cART

INTERVENTIONALInicio: 1 de ago de 2011ID: NCT01384682

CompletadoFase 2ClinicalTrials.gov

A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose Response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

INTERVENTIONALInicio: 1 de oct de 2003ID: NCT00071097

TerminadoFase 3ClinicalTrials.gov

A Multi-center, Double-blinded and Open-label Extension Study to Evaluate the Efficacy and Safety of Ligelizumab as Retreatment, Self-administered Therapy and Monotherapy in Chronic Spontaneous Urticaria Patients Who Completed Studies CQGE031C2302, CQGE031C2303, CQGE031C2202 or CQGE031C1301

INTERVENTIONALInicio: 8 de abr de 2020ID: NCT04210843

CompletadoFase 2ClinicalTrials.gov

A Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerance, Pharmacokinetics and Antiviral Activity of Amdoxovir and Zidovudine in Untreated HIV-1 Infected Subjects Currently Untreated

INTERVENTIONALInicio: 1 de feb de 2007ID: NCT00432016

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants

INTERVENTIONALInicio: 25 de ago de 2025ID: NCT07160244

TerminadoFase 2ClinicalTrials.gov

NASH EXploratory Single and COmbination Treatment (NEXSCOT): An Open Label, Multicenter, Platform Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Various Single and Combination Treatments in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) Who Manifest a Non-alcoholic Steatohepatitis (NASH)-Like Biomarker Phenotype

INTERVENTIONALInicio: 4 de jun de 2020ID: NCT04147195

TerminadoFase 3ClinicalTrials.gov

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor

INTERVENTIONALInicio: 23 de dic de 2022ID: NCT05605093

TerminadoFase 3ClinicalTrials.gov

Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation

INTERVENTIONALInicio: 1 de mar de 2007ID: NCT00447902

CompletadoFase 4ClinicalTrials.gov

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines in Children Under 2 Years Old in Argentina

INTERVENTIONALInicio: 23 de nov de 2015ID: NCT03368495

DesconocidoFase 2ClinicalTrials.gov

Randomised Phase II Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population (rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV).

INTERVENTIONALInicio: 26 de jul de 2021ID: NCT04983537

CompletadoFase 2ClinicalTrials.gov

A Phase II Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Cotadutide in Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

INTERVENTIONALInicio: 14 de jul de 2022ID: NCT05364931

TerminadoFase 3ClinicalTrials.gov

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis

INTERVENTIONALInicio: 25 de jun de 2020ID: NCT04365868

Aún no reclutaFase 4ClinicalTrials.gov

Efficacy and Safety of Doravirine in the Rapid Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-1positive Patients Without Prior Treatment

INTERVENTIONALInicio: 13 de jul de 2026ID: NCT07357584

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)

INTERVENTIONALInicio: 22 de dic de 2020ID: NCT04677543